Abbott Labs (ABT) is a consistent performer with diversified healthcare operations, including pharmaceuticals, diagnostics, medical nutrition products, and medical devices/stents. ABT is back to the lower end of its trading range near 50 bucks, presenting an excellent entry point with a 2.8% dividend yield and forward PE of about 14X.
Celgene (CELG) is also trading at the low end of its trading range around 50 bucks as a large-cap growth stock focused on cancer biotech products and research with an estimated PEG ratio below one.
The accompanying table presents my 60 defensive growth stock picks at the recently launched online investing site Inner8.com , which I wrote about yesterday. My picks are focused on healthcare and consumer staples, along with some cash rich tech companies such as Microsoft (MSFT). My picks include companies across the entire spectrum of market cap and risk in the biotech industry, ranging from top performers such as Amgen (AMGN) and Celgene (CELG) to small and micro-cap picks such as Discovery Labs (DSCO),
Despite the notion of investing in the healthcare sector as a safe haven, the following six companies (APPY, CMED, CYPB, DSCO, MYL, PFE) are all down sharply over the past year despite solid underlying fundamentals, which are largely unaffected by global economic conditions.
Diagnostics
China Medical (CMED) is trading near its IPO levels of August 2005 despite excellent growth prospects and a PEG ratio of 0.3X, a forward PE of 8X, and a dividend yield of 1.8%. For some perspective on the velocity of the downturn in CMED, the stock
Bullish "Mojo Crossover"! Get on the list for our "Hot Conference" chat room and trade with Mojo and 100 fellow traders coming soon (1st 100)! Just send an email (Subject: Hot Conference) http://modj97-predictwallstreet.blogspot.com The blog has updated charts for today's trading too.
This company develops, manufactures and sells hi-tech medical equipment of various sorts. They can even cure cancer :) CMED has been generating 50 % profit (on average!) and grows 50 % per year, and it does pay dividends. Earnings per share for 2005, 2006 and 2007: 0.59, 0.79 and 1.06. Consensus EPS estimates for 2008 and 2009: 1.65 and 2.15. China Medical Technologies is a frequent talker in respectable conferences, and they have deals with major Chinese hospitals. For example: "China Medical Technologies to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and M...
Abbott Labs (ABT) is a consistent performer with diversified healthcare operations, including pharmaceuticals, diagnostics, medical nutrition products, and medical devices/stents. ABT is back to the lower end of its trading range near 50 bucks, presenting an excellent entry point with a 2.8% dividend yield and forward PE of about 14X.
Celgene (CELG) is also trading at the low end of its trading range around 50 bucks as a large-cap growth stock focused on cancer biotech products and research with an estimated PEG ratio below one.
China Medical (CMED) is trading near its IPO levels of August 20...
Many investors have found that in this turbulent market, gains often come in the “two steps forward, one step back” variety. Such is the case with China Medical Technologies, Inc. (ADR), (CMED) over the past two weeks. The company announced earnings August 4th after the close which sent the stock sprinting higher. [...]
Monday: Economic Empire (-26), Cap U & IP (76.6%, -0.1%) Earnings Lowe’s (LOW), Target (TGT), Ctrip.com (CTRP)
Tuesday: Economic PPI & Core (0.2%, -1.5%) Earnings China Med (CMED), Home Depot (HD), Medtronic (MDT), ReneSola (SOL), Saks (SKS), Jack In The Box (JBX), La-Z-Boy (LZB)
Wednesday: Economic Weekly Crude, Build P’s & Housing (770K, 780K), CPI & Core (0.2%, -0.8%), FOMC Minutes Earnings BJ’s (BJ), LDK Solar (LDK), Ross (ROST), Trina (TSL), Dress Barn (DBRN), Gymboree (GYMB), Hot Topic (HOTT), Intuit (INTU), Limited (LTD), Men’s Wearhouse (MW), PETsMART (PETM), Woodward Governor (WGOV)
Many investors have found that in this turbulent market, gains often come in the “two steps forward, one step back” variety. Such is the case with China Medical Technologies, Inc. (ADR), (CMED) over the past two weeks. The company announced earnings August 4th after the close which sent the stock sprinting higher. [...]
Despite the notion of investing in the healthcare sector as a safe haven, the following six companies (APPY, CMED, CYPB, DSCO, MYL, PFE) are all down sharply over the past year despite solid underlying fundamentals, which are largely unaffected by global economic conditions.
Diagnostics
China Medical (CMED) is trading near its IPO levels of August 2005 despite excellent growth prospects and a PEG ratio of 0.3X, a forward PE of 8X, and a dividend yield of 1.8%. For some perspective on the velocity of the downturn in CMED, the stock opened this week trading in the low thirties and I bought shar...
Data powered by QuoteMedia.
All Rights Reserved.
Data delayed 15 to 20 minutes unless otherwise indicated.
Terms of Use.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.